APGE - Apogee Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$109.44
DETAILS
HIGH:
$140.00
LOW:
$83.00
MEDIAN:
$103.00
CONSENSUS:
$109.44
UPSIDE:
34.84%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 0.0% |
| EBIT Margin | 0.0% |
| EBITDA Margin | 0.0% |
| Operating Margin | 0.0% |
| Pretax Margin | 0.0% |
| Cont. Ops Margin | 0.0% |
| Net Margin | 0.0% |
| Bottom Line Margin | 0.0% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 26.57 |
| Quick Ratio | 26.57 |
| Solvency Ratio | -7.652 |
| Cash Ratio | 4.71 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-17.91
Peers avg: 29.9
|
| PEG Ratio | -0.64 |
| Forward PEG | -0.64 |
| Price/Book | 5.07 |
| Price/Sales | 0.00 |
| Price/FCF | -19.69 |
| Price/Op Cash Flow | -20.14 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0094 |
| Debt/Equity | 0.0098 |
| Debt/Capital | 0.0097 |
| Long-Term Debt/Capital | 0.0059 |
| Financial Leverage | 1.04 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.00 |
| Operating Cash Flow Ratio | -8.151 |
| Operating Cash Flow/Sales | 0.0% |
| Free Cash Flow/Operating Cash Flow | 102.3% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -81.18 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -64.91 |
| Operating Cash Flow Coverage | -25.70 |
| Capital Expenditure Coverage | -44.19 |
| Dividend + Capital Expenditure Coverage | -44.19 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.00 |
| EPS | -4.216 |
| Debt/Share | 0.1458 |
| Cash/Share | 12.03 |
| Book Value/Share | 14.89 |
| Tangible BV/Share | 14.89 |
| Equity/Share | 14.89 |
| Operating Cash Flow/Share | -3.748 |
| Capital Expenditure/Share | 0.085 |
| FCF/Share | -3.832 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.001 |
| Earnings Before Tax/EBIT | 0.895 |
| Price/Fair Value | 5.07 |
| Debt/Market Cap | 0.0019 |
| Effective Tax Rate | -0.1% |
| Enterprise Value Multiple | -15.69 |